To further confirm the value of autoantibody to GNAS in early diagnosis of HCC, another independent dataset comprising 48 NC sera and 44 serial sera from 11 HCC patients, who were tracked more than one year before and after diagnosis of HCC, was applied for follow-up evaluation. This evidence concerns the gene GNAS and hepatocellular carcinoma.